Windlas Biotech Share Price

Windlas Biotech Limited is a domestic pharmaceutical formulations contract development and manufacturing organization (CDMO). Its portfolio of CDMO solutions includes product development, licensing, and commercial manufacturing of complex drugs and dosage forms. Its product development and manufacturing capabilities in complex generic products by developing products, including alternate dosages, such as, medicated mouth sprays; coating technologies, including, pellet coating using bottom spray, API coating, pH dependent coating and nanosized crystals; nutraceuticals dosages, including, biscuits, protein powder, supplements, chocolate bars and malt based foods, and ayurvedic products, such as wellness products, hair oils and cough syrups. Its four fungible, Schedule-M compliant OSD/OLD manufacturing facilities are located in Dehradun, Uttarakhand, India. It specializes in manufacturing formulations, solid pharmaceutical dosage forms, liquid pharmaceutical dosage forms and injectables. As of 25 May 2026, Windlas Biotech share price is ₹784.40. The stock opened at ₹804.95, compared to its previous close of ₹789.95. During today's trading session, Windlas Biotech share price moved in the range of ₹770.15 to ₹805.00, with an average price of ₹787.58 for the day. Looking at its last 52-week, the stock has touched a low of ₹770.15 and a high of ₹805.00. On the performance front, Windlas Biotech share price has declined by 0.52% over the last six months and is down 18.64% on a year-on-year basis.

The market capitalization of Windlas Biotech is ₹1,634 Crs, with a P/E ratio of 24.6 and a dividend yield of 0.81%.